Work

PS5-09-11: Dose-dense Paclitaxel with Empegfilgrastim vs weekly Paclitaxel in luminal B HER2-negative early breast cancer (PULSE trial)

Year: 2026

Type: article

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-09-11

Authors: P. Krivorotko, N. Amirov, V. Mortada, A. Emelyanov, R. Pesotskiy, E. Zhiltsova, T. Tabagua

Institution: Institute of Oncology NN Petrov

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129544382

FWCI:

Cites:

Cited by:

Related to: